Bharat Biotech Says Intranasal Covid Vaccine Found Safe In Booster Trials

Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe.